Trial intelligence / Profile preview

Praziquantel for asymptomatic Plasmodium falciparum infection in Gabonese adults

PACTR202206584817951Phase 2Completed

Start
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of praziquantel in malaria and Falciparum malaria (PF) (2 arms). Primary endpoint: Proportion of participants with microscopically determined parasite clearance on day 7. Started Mar 2022; status: completed.

02

Drugs

praziquantel
03

Conditions

malariaFalciparum malaria (PF)

Beyond the preview

Go deeper on PACTR202206584817951.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202206584817951.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call